STI Pharma Funding: How Much Did They Raise & Key Investors

How Much Did STI Pharma Raise?
Funding & Key Investors

STI Pharma, a specialty pharmaceutical firm, has secured $150K in total capital, with its most recent financing round bringing in $150K. This major strategic investment underscores the company's progression through its late-stage development phase. The company's financial trajectory indicates a significant push towards scaling its operations and market presence.

What is STI Pharma?

STI Pharma

Manufacturing

Pharmaceuticals

Business Services

Founded in 2008 and headquartered in Newtown, PA, STI Pharma is a specialty pharmaceutical company dedicated to the acquisition, development, and marketing of high-quality pharmaceutical products. The company strategically concentrates its efforts on the oncology and injectables sectors, areas known for their high growth potential and critical unmet medical needs. STI Pharma's business model is built upon leveraging industry veteran expertise to identify and commercialize promising therapeutic assets.

How much funding has STI Pharma raised?

STI Pharma has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

What's next for STI Pharma?

With the recent influx of capital and its positioning in the late-stage funding environment, STI Pharma is poised for significant expansion. The strategic investment is likely to fuel further research and development initiatives, enhance its product pipeline, and bolster its commercialization efforts, particularly within the oncology and injectables markets. This financial backing is expected to accelerate STI Pharma's mission to bring vital treatments to patients and solidify its market standing.

See full STI Pharma company page

See More Financial Insights